Wizdolphin has investors interested in acquiring companies and laboratories in the pharmaceutical, biogenetic, and related sectors, including drugs for humans and animals, probiotics, and nutritional components.

Target companies must be profitable and possess, among other characteristics, a long-standing track record in the industry, growth potential, notable differentiating factors, a loyal customer base, and well-trained and experienced human capital.

Companies are sought primarily due to the absence of generational succession among partners, retirement, early retirement, illness, or job fatigue. For those companies that meet these criteria and are considering a sale, the opportunity to contact without obligation is available.